Join to View Full Profile
501 Saunders AveSte 200Tyler, TX 75702
Phone+1 903-579-9800
Fax+1 903-592-5988
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 3 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Donald Richards, MD is an oncologist in Tyler, Texas. He is currently licensed to practice medicine in Texas and Washington.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 1986 - 1988- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 1983 - 1986
- The University of Texas Health Science Center at San AntonioClass of 1983
Certifications & Licensure
TX State Medical License 1985 - 2028
WA State Medical License 1988 - 1992
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification iKnowMed EHR, McKesson, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification iKnowMed EHR, McKesson, 2012, 2014-2017
Publications & Presentations
PubMed
- 5 citationsLenvatinib plus Pembrolizumab Following Immune Checkpoint Inhibitor Treatment in Patients with Metastatic Clear Cell Renal Cell Carcinoma: Results from Study 111/KEYNO...Chung-Han Lee, Amishi Yogesh Shah, Arpit Rao, Matthew H Taylor, Christopher Di Simone
European Urology. 2024-11-01 - 9 citationsPerformance of a Cell-Free DNA-Based Multi-cancer Detection Test in Individuals Presenting With Symptoms Suspicious for Cancers.Alan H Bryce, David D Thiel, Michael V Seiden, Donald Richards, Ying Luan
JCO Precision Oncology. 2023-07-01 - 28 citationsMRTX-500 Phase 2 Trial: Sitravatinib With Nivolumab in Patients With Nonsquamous NSCLC Progressing On or After Checkpoint Inhibitor Therapy or Chemotherapy.Kai He, David Berz, Shirish M Gadgeel, Wade T Iams, Debora S Bruno
Journal of Thoracic Oncology. 2023-07-01
Press Mentions
Tyler Cancer Center Treating Patients While Maintaining Safe EnvironmentApril 23rd, 2020
POLO Trial Underscores Need for Screening in Metastatic Pancreatic CancerOctober 1st, 2019
Oncologists from the US Oncology Network and US Oncology Research to Present Data from More Than 40 Abstracts During the 54May 30th, 2018
